Resected Pancreatic Cancer: Why Wait for the Inevitable?

Dr. John Marshall reports on a retrospective study suggesting that maintenance with capecitabine is a promising option in patients with resected pancreatic adenocarcinoma after adjuvant therapy.
Source: Medscape Gastroenterology Podcast - Category: Gastroenterology Authors: Source Type: podcasts